Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cano Health, Inc. stock logo
CANO
Cano Health
$3.81
$1.74
$190.00
$12.39M0.05423,785 shs159,142 shs
KnowBe4, Inc. stock logo
KNBE
KnowBe4
$24.89
$24.85
$13.78
$26.00
$4.35B0.321.34 million shsN/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
$22.03
-1.9%
$21.64
$12.32
$32.10
$1.06B-0.38684,069 shs598,918 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cano Health, Inc. stock logo
CANO
Cano Health
0.00%0.00%0.00%0.00%+70.26%
KnowBe4, Inc. stock logo
KNBE
KnowBe4
0.00%0.00%0.00%0.00%0.00%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
-1.87%+1.45%-0.50%-4.22%+35.81%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cano Health, Inc. stock logo
CANO
Cano Health
0.2614 of 5 stars
2.80.00.00.00.00.80.0
KnowBe4, Inc. stock logo
KNBE
KnowBe4
N/AN/AN/AN/AN/AN/AN/AN/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
3.5431 of 5 stars
3.52.00.04.72.00.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cano Health, Inc. stock logo
CANO
Cano Health
1.67
Reduce$2.28∞ Upside
KnowBe4, Inc. stock logo
KNBE
KnowBe4
N/AN/AN/AN/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
3.00
Buy$131.00494.64% Upside

Current Analyst Ratings

Latest CANO, KNBE, and SAVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$124.00 ➝ $131.00
3/5/2024
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$124.00
(Data available from 6/1/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cano Health, Inc. stock logo
CANO
Cano Health
$2.74B0.00N/A0.03$100.28 per share0.00
KnowBe4, Inc. stock logo
KNBE
KnowBe4
$246.30M17.65$0.26 per share94.66$1.25 per share19.91
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/AN/AN/AN/A$1.64 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cano Health, Inc. stock logo
CANO
Cano Health
-$207.27M-$215.87N/AN/AN/A-18.62%-133.59%-19.18%N/A
KnowBe4, Inc. stock logo
KNBE
KnowBe4
-$11.85M$0.10248.90311.136.215.02%11.31%4.46%N/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
-$97.22M-$2.17N/A13.52N/AN/A-66.08%-53.72%8/1/2024 (Estimated)

Latest CANO, KNBE, and SAVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/10/2024Q1 2024
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
-$0.51-$1.41-$0.90-$2.39N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cano Health, Inc. stock logo
CANO
Cano Health
N/AN/AN/AN/AN/A
KnowBe4, Inc. stock logo
KNBE
KnowBe4
N/AN/AN/AN/AN/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cano Health, Inc. stock logo
CANO
Cano Health
3.95
0.40
0.40
KnowBe4, Inc. stock logo
KNBE
KnowBe4
N/A
1.62
1.62
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/A
1.74
1.74

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cano Health, Inc. stock logo
CANO
Cano Health
35.99%
KnowBe4, Inc. stock logo
KNBE
KnowBe4
91.90%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
38.05%

Insider Ownership

CompanyInsider Ownership
Cano Health, Inc. stock logo
CANO
Cano Health
13.93%
KnowBe4, Inc. stock logo
KNBE
KnowBe4
5.03%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
9.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cano Health, Inc. stock logo
CANO
Cano Health
4,3655.41 million4.65 millionOptionable
KnowBe4, Inc. stock logo
KNBE
KnowBe4
1,366174.70 million165.91 millionNot Optionable
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
2947.98 million43.66 millionOptionable

CANO, KNBE, and SAVA Headlines

Recent News About These Companies

National Biosafety Authority ready to release three GMO crops
When anti-poverty grant fail to end rural poverty-3
Cassava Sciences (NASDAQ:SAVA) Shares Down 6%
Cassava Sciences (NASDAQ:SAVA) Trading Up 9.8%
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cano Health logo

Cano Health

NYSE:CANO
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
KnowBe4 logo

KnowBe4

NASDAQ:KNBE
KnowBe4, Inc. engages in the development, marketing, and sale of its Software-as-a-Service-based security awareness platform. The company provides a platform incorporating security awareness training and simulated phishing with analytics and reporting that helps organizations manage the ongoing problem of social engineering. Its products include Kevin Mitnick Security Awareness Training, a security awareness training product; Compliance Plus, a compliance training product, which enables organizations to offer their employees with relevant, timely, and engaging compliance content across a range of topics from data privacy to diversity, equity, and inclusion; PhishER, its security orchestration, automation, and response product, which enables security professionals to prioritize and automate security workstreams in response to attacks targeted at the human layer; and KnowBe4 Compliance Manager, its governance, risk, and compliance product that enables organizations to analyze security risk and automate the management of compliance and audit functions. The company also offers Security Coach, a solution to address human behavior risks through human detection and response; and PasswordIQ that would be used to mitigate risk related to password hygiene issues, such as weak or breached passwords. It serves its customers directly through inside sales teams for enterprise and small and medium businesses, as well as indirectly through channel partners and managed service providers. The company was formerly known as SEQRIT, LLC and changed its name to KnowBe4, Inc. in January 2016. KnowBe4, Inc. was founded in 2010 and is headquartered in Clearwater, Florida.
Cassava Sciences logo

Cassava Sciences

NASDAQ:SAVA
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.